IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

  1. Mouraux, A.
  2. Bloms-Funke, P.
  3. Boesl, I.
  4. Caspani, O.
  5. Chapman, S.C.
  6. Di Stefano, G.
  7. Finnerup, N.B.
  8. Garcia-Larrea, L.
  9. Goetz, M.
  10. Kostenko, A.
  11. Pelz, B.
  12. Pogatzki-Zahn, E.
  13. Schubart, K.
  14. Stouffs, A.
  15. Truini, A.
  16. Tracey, I.
  17. Troconiz, I.F.
  18. Van Niel, J.
  19. Vela, J.M.
  20. Vincent, K.
  21. Vollert, J.
  22. Wanigasekera, V.
  23. Wittayer, M.
  24. Phillips, K.G.
  25. Treede, R.-D.
Journal:
Trials

ISSN: 1745-6215

Year of publication: 2021

Volume: 22

Issue: 1

Type: Article

DOI: 10.1186/S13063-021-05272-Y GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus